Jean‐claude Chermann

Jean‐claude Chermann's AcademicInfluence.com Rankings

Biology

#11201

World Rank

#14580

Historical Rank

Virology

#269

World Rank

#276

Historical Rank

Immunology

#720

World Rank

#742

Historical Rank

biology Degrees

Download Badge

Biology

Jean‐claude Chermann's Degrees

PhD Virology Université Paris Cité

Why Is Jean‐claude Chermann Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Jean‐claude Chermann's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). (1983) (6417)
Selective tropism of lymphadenopathy associated virus (LAV) for helper-inducer T lymphocytes. (1984) (951)
Cellular proteins bound to immunodeficiency viruses: implications for pathogenesis and vaccines. (1992) (599)
Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). 1983. (2004) (519)
Adaptation of lymphadenopathy associated virus (LAV) to replication in EBV-transformed B lymphoblastoid cell lines. (1984) (325)
INACTIVATION OF LYMPHADENOPATHY-ASSOCIATED VIRUS BY HEAT, GAMMA RAYS, AND ULTRAVIOLET LIGHT (1985) (276)
INACTIVATION OF LYMPHADENOPATHY ASSOCIATED VIRUS BY CHEMICAL DISINFECTANTS (1984) (257)
ISOLATION OF NEW LYMPHOTROPIC RETROVIRUS FROM TWO SIBLINGS WITH HAEMOPHILIA B, ONE WITH AIDS (1984) (245)
DETECTION OF IgG ANTIBODIES TO LYMPHADENOPATHY-ASSOCIATED VIRUS IN PATIENTS WITH AIDS OR LYMPHADENOPATHY SYNDROME (1984) (228)
Risk factors for AIDS and HIV seropositivity in homosexual men. (1987) (181)
Lymphadenopathy associated virus infection of a blood donor--recipient pair with acquired immunodeficiency syndrome. (1984) (181)
Differential inhibitory effects of various flavonoids on the activities of reverse transcriptase and cellular DNA and RNA polymerases. (1990) (177)
Antiviral Activities of Sulfated Polysaccharides Isolated from Sphaerococcus coronopifolius (Rhodophytha, Gigartinales) and Boergeseniella thuyoides (Rhodophyta, Ceramiales) (2011) (162)
Accumulation of defective viral genomes in peripheral blood mononuclear cells of human immunodeficiency virus type 1-infected individuals (1997) (152)
ANTIMONIOTUNGSTATE (HPA 23) TREATMENT OF THREE PATIENTS WITH AIDS AND ONE WITH PRODROME (1985) (150)
Characterization of the RNA dependent DNA polymerase of a new human T-lymphotropic retrovirus (lymphadenopathy associated virus). (1984) (148)
Identification and antigenicity of the major envelope glycoprotein of lymphadenopathy-associated virus. (1985) (144)
Molecular cloning of lymphadenopathy-associated virus (1984) (137)
Antibodies to the core protein of lymphadenopathy-associated virus (LAV) in patients with AIDS. (1984) (124)
Prevalence of antibodies to lymphadenopathy-associated retrovirus in African patients with AIDS. (1984) (123)
Lymphadenopathy-associated viral antibody in AIDS. Immune correlations and definition of a carrier state. (1984) (122)
INFECTION OF CHIMPANZEES WITH LYMPHADENOPATHY-ASSOCIATED VIRUS (1984) (116)
Nucleotide sequence of HIV1-NDK: a highly cytopathic strain of the human immunodeficiency virus. (1989) (116)
In vivo inhibition of murine leukemia and sarcoma viruses by the heteropolyanion 5-tungsto-2-antimoniate. (1974) (99)
Fetal human immunodeficiency virus type 1 infection of different organs in the second trimester. (1991) (91)
ISOLATION OF HUMAN T-LYMPHOTROPIC RETROVIRUS (LAV) FROM ZAIRIAN MARRIED COUPLE, ONE WITH AIDS, ONE WITH PRODROMES (1984) (89)
Human immunodeficiency virus can infect the apical and basolateral surfaces of human colonic epithelial cells. (1991) (83)
Soluble IL-2 receptor in AIDS. Correlation of its serum level with the classification of HIV-induced diseases and its characterization. (1989) (78)
A new type of retrovirus isolated from patients presenting with lymphadenopathy and acquired immune deficiency syndrome: Structural and antigenic relatedness with equine infectious anaemia virus (1984) (77)
Inhibition of reverse transcriptase activity by a flavonoid compound, 5,6,7-trihydroxyflavone. (1989) (75)
Combined chemoimmunostimulation therapy against murine leukemia. (1972) (74)
Inhibition of human immunodeficiency virus type 1 reverse transcriptase dimerization using synthetic peptides derived from the connection domain. (1994) (73)
Detection and titration of neutralizing antibodies to HIV using an inhibition of the cytopathic effect of the virus on MT4 cells. (1987) (71)
Inhibition of RNA-dependent DNA polymerase of murine oncornaviruses by ammonium-5-tungsto-2-antimoniate. (1975) (69)
Screening for lymphadenopathy/AIDS virus in bone marrow-transplant recipients. (1986) (68)
Lymphadenopathy-associated virus isolated from bronchoalveolar lavage fluid in AIDS-related complex with lymphoid interstitial pneumonitis. (1985) (68)
Susceptibility of cultured human trophoblasts to infection with human immunodeficiency virus type 1. (1991) (67)
Human transformed trophoblast-derived cells lacking CD4 receptor exhibit restricted permissiveness for human immunodeficiency virus type 1 (1991) (66)
In vitro anti-HIV activity of sulfated cell-wall polysaccharides from gametic, carposporic and tetrasporic stages of the Mediterranean red alga Asparagopsis armata. (2001) (60)
Productive infection of CD4+ cells by selected HIV strains is not inhibited by anti-CD4 monoclonal antibodies. (1991) (60)
Isolation of a new retrovirus in a patient at risk for acquired immunodeficiency syndrome. (1983) (58)
Human colon epithelial cells productively infected with human immunodeficiency virus show impaired differentiation and altered secretion (1992) (57)
Antiviral and anticoagulant activities of a water-soluble fraction of the marine diatom Haslea ostrearia. (1999) (56)
Inhibition of RNA-dependent DNA polymerases of AIDS and SAIDS retroviruses by HPA-23 (ammonium-21-tungsto-9-antimoniate) (1985) (56)
Structure-activity relationships in a series of newly synthesized 1-amino-substituted ellipticine derivatives. (1980) (55)
Replication of human immunodeficiency virus type 1 in primary cultured placental cells. (1991) (51)
Antilymphocyte antibodies and seropositivity for retroviruses in groups at high risk for AIDS. (1985) (48)
The effects of HIV on hematopoiesis (1992) (47)
HIGH PREVALENCE OF LYMPHADENOPATHY VIRUS (LAV) IN EUROPEAN HAEMOPHILIACS (1984) (46)
Composition and antiviral activities of a sulfated polysaccharide from schizymenia dubyi (rhodophyta, gigartinales) (1993) (45)
Annual variation in composition andin vitro anti-HIV-1 activity of the sulfated glucuronogalactan fromSchizymenia dubyi (Rhodophyta, Gigartinales) (1996) (45)
Lymphadenopathy associated virus and its etiological role in AIDS. (1984) (44)
Circulating cell adhesion molecules in HIV1-infected patients as indicator markers for AIDS progression. (1997) (44)
RESISTANCE OF AIDS VIRUS AT ROOM TEMPERATURE (1985) (43)
Surface CD4 density remains constant on lymphocytes of HIV-infected patients in the progression of disease. (1991) (40)
The gag precursor contains a specific HIV‐1 protease cleavage site between the NC (P7) and P1 proteins (1993) (40)
Inactivation and Partition of Human Immunodeficiency Virus during Kistler and Nitschmann Fractionation of Human Blood Plasma 1 (1988) (38)
ACQUIRED IMMUNODEFICIENCY SYNDROME AFTER TRAVELLING IN AFRICA: AN EPIDEMIOLOGICAL STUDY IN SEVENTEEN CAUCASIAN PATIENTS (1987) (37)
Involvement of HIV nef protein in abnormal hematopoiesis in AIDS: in vitro study on bone marrow progenitor cells (1994) (37)
Effect of ammonium 5-tungsto-2-antimoniate on encephalomyocarditis and vesicular stomatitis virus infections in mice. (1976) (37)
Distinctive pattern of infection and replication of HIV1 strains in blood-derived macrophages. (1992) (36)
Antitumor amino-substituted pyrido[3',4':4,5]pyrrolo[2,3-g]isoquinolines and pyrido[4,3-b]carbazole derivatives: synthesis and evaluation of compounds resulting from new side chain and heterocycle modifications. (1983) (33)
Swainsonine protects both murine and human haematopoietic systems from chemotherapeutic toxicity (1999) (33)
Selected human immunodeficiency virus replicates preferentially through the basolateral surface of differentiated human colon epithelial cells. (1991) (33)
A monoclonal antibody against LAV gag precursor: use for viral protein analysis and antigenic expression in infected cells. (1986) (32)
New bicyclam-AZT conjugates: design, synthesis, anti-HIV evaluation, and their interaction with CXCR-4 coreceptor. (1999) (32)
An early postinfection signal mediated by monoclonal anti-beta 2 microglobulin antibody is responsible for delayed production of human immunodeficiency virus type 1 in peripheral blood mononuclear cells (1990) (32)
Replication of the human immunodeficiency virus 1 and impaired differentiation of T cells after in vitro infection of bone marrow immature T cells. (1989) (31)
TRANSMISSION EXPERIMENTS WITH HUMAN T-LYMPHOTROPIC RETROVIRUSES AND HUMAN AIDS TISSUE (1984) (31)
Transient antibody to lymphadenopathy-associated virus/human T-lymphotropic virus type III and T-lymphocyte abnormalities in the wife of a man who developed the acquired immunodeficiency syndrome. (1985) (31)
In vitro effects of silicotungstate on some RNA viruses. (1973) (30)
Antitumoral activity of dipyrido [4,3-b] [3,4-f] indoles on L 1210 leukemia. (1980) (30)
Inhibition of rabies virus in vitro by the ammonium-5-tungsto-2-antimoniate. (1978) (30)
Isolation of lymphadenopathy-associated virus (LAV) and detection of LAV antibodies from US patients with AIDS. (1985) (29)
Clinical and immunological restoration in patients with AIDS after marrow transplantation, using lymphocyte transfusions from the marrow donor. (1987) (29)
New 3'-azido-3'-deoxythymidin-5'-yl O-(omega-hydroxyalkyl) carbonate prodrugs: synthesis and anti-HIV evaluation. (2001) (28)
HIV-I AND HIV-II DOUBLE INFECTION IN CENTRAL AFRICAN REPUBLIC (1986) (28)
Differences in replication and cytopathogenicity of human immunodeficiency virus type 1 (HIV-1) are not determined by long terminal repeats (LTR). (1990) (27)
Lectin-mediated effects on HIV type 1 infection in vitro. (1995) (26)
Correlation between structure of polyoxotungstates and their inhibitory activity on polymerases. (1983) (26)
Interface Peptides as Structure-based Human Immunodeficiency Virus Reverse Transcriptase Inhibitors (*) (1995) (26)
POSSIBLE TRANSMISSION OF A HUMAN LYMPHOTROPIC RETROVIRUS (LAV) FROM MOTHER TO INFANT WITH AIDS (1984) (25)
Modulation of normal human erythropoietic progenitor cells in long-term liquid cultures after HIV-1 infection. (1992) (24)
In vivo effect of a new mineral condensed ion (HPA 39) on murine Friend leukaemia. (1981) (24)
Sequences related to mouse mammary tumor virus genome in tumor cells and lymphocytes from patients with breast cancer. (1984) (24)
Inhibition of human immunodeficiency virus type 1 replication by phosphonoformate- and phosphonoacetate-2',3'-dideoxy-3'-thiacytidine conjugates. (1994) (23)
Search for compounds which have an inhibitory effect on rhabdovirus multiplication In Vitro (1983) (22)
Inhibition of HIV by an anti-HIV protease synthetic peptide blocks an early step of viral replication. (1992) (22)
Powerful New Inhibitor of Murine Leukaemia and Sarcoma Viruses (1970) (21)
HIV1 cytopathogenicity-genetic difference between direct cytotoxic and fusogenic effect. (1992) (21)
Differential inhibition of various mammalian DNA polymerase activities by ammonium 21-tungsto-9-antimoniate (HPA23). (1988) (20)
Expression of an immunogenic region of HIV by a filamentous bacteriophage vector. (1991) (19)
Effects of 5-tungsto-2-antimoniate in oncogenic DNA and RNA virus-cell systems. (1977) (19)
The env gene variability is not directly related to the high cytopathogenicity of an HIV1 variant. (1990) (19)
Anti-beta 2-microglobulin monoclonal antibodies mediate a delay in HIV1 cytopathic effect on MT4 cells. (1990) (18)
Enhancement of retrovirus production by anti-interferon serum. (1979) (18)
Immunostimulating Activity of Whole Cells, Cell-Walls and Fractions of Anaerobic Corynebacteria (1974) (17)
Inhibition of tumour virus RNA-dependent DNA polymerase by the heteropolyan ion, silicotungstate. (1973) (17)
Modulation by the polyoxotungstate HPA-23 of Epstein-Barr virus early antigen expression in Raji cells treated with iododeoxyuridine. (1984) (17)
Sexual and Mother‐to‐Child Transmission of the Human Immunodeficiency Virus Type 1: A Review (1998) (17)
Rationale for a vaccine using cellular-derived epitope presented by HIV isolates. (1999) (16)
[Study of HIV localization in sperm]. (1997) (16)
Peripheral blood adherent cells from AIDS patients inhibit normal T-colony growth through decreased expression of interleukin 2-receptors and production of interleukin 2. (1987) (16)
Differential inhibition of the activities of reverse transcriptase and various cellular DNA polymerases by a traditional Kampo drug, sho-saiko-to. (1990) (16)
LYMPHADENOPATHY SYNDROME AND SEROCONVERSION TWO MONTHS AFTER SINGLE USE OF NEEDLE SHARED WITH AN AIDS PATIENT (1986) (16)
Primary intestinal epithelial cells can be infected with laboratory-adapted strain HIV type 1 NDK but not with clinical primary isolates. (1998) (15)
Severe in vitro inhibition of erythropoiesis and transient stimulation of granulopoiesis after bone‐marrow infection with eight different HIV‐2 isolates (1992) (15)
Retroviruses and AIDS (1985) (15)
Statine based tripeptides as potent inhibitors of HIV-1 replication. (1992) (15)
Transmission of lymphadenopathy-associated virus/human T lymphotropic virus type III in sexual partners. Seropositivity does not predict infectivity in all cases. (1986) (15)
A common antigenic constituent in various purified Salmonella endotoxins. (1973) (14)
Standardized nested polymerase chain reaction-based assay for detection of human immunodeficiency virus type 1 DNA in whole blood lysates (1993) (14)
Synthesis and antiviral activity of new anti-HIV amprenavir bioisosteres. (2002) (14)
Differential HIV replication and HIV-induced interferon production in mononuclear phagocytes: relationship to cell maturation. (1991) (13)
HIV-associated diseases: acute and regressive encephalopathy in a seropositive man. (1990) (13)
Synthesis and anti-human immunodeficiency virus type 1 activities of new peptido-nucleoside analogues (1995) (13)
HIV as the cause of AIDS and associated diseases (2004) (13)
Role of Kaposi's sarcoma cells in recruitment of circulating leukocytes: implications in pathogenesis. (1998) (13)
2-l-Rhamnopyranosyl[1,2,4]triazolo[1,5-a]pyridine. 4' and 3' Oxidation products. Synthesis and structure-activity relationships. (1981) (12)
HIV-1 infectivity of human carcinoma cell lines lacking CD4 receptors. (1992) (12)
The human immunodeficiency virus (HIV) gag gene product p18 is responsible for enhanced fusogenicity and host range tropism of the highly cytopathic HIV-1-NDK strain (1992) (12)
Genomic variability of selected LAV-related AIDS retroviruses. (1986) (12)
Synthesis and antiviral activity of N-4′-dihydropyridinyl and dihydroquinolinylcarbonyl-2-hydroxymethyl-5-[cytosin-1′-yl]-1,3-oxathiolane derivatives against human immunodeficiency virus and duck hepatitis B virus (1996) (12)
A novel epitope R7V common to all HIV-1 isolates is recognized by neutralizing IgG found in HIV-infected patients and immunized rabbits. (1999) (11)
HIV inactivation by a spermicide containing benzalkonium chloride (1987) (11)
Synthesis and anti-HIV activity of alpha-thiophenoxy-hydroxyethylamide derivatives. (1999) (11)
Humoral response in rabbits immunized with calcium phosphate adjuvanted HIV-1 gp160 antigen. (1994) (11)
Anti-R7V antibodies as therapeutics for HIV-infected patients in failure of HAART. (2002) (11)
Epidemiology of HIV1 infection among randomized representative Central African populations (1987) (11)
Sequence analysis of original HIV-1 (1991) (11)
Human T-lymphoblastoid cells selected for growth in serum-free medium provide new tools for study of HIV replication and cytopathogenicity. (1991) (10)
Use of proline bioisosteres in potential HIV protease inhibitors: phenylalanine-2-thiophenoxy-3-pyrrolidinone: synthesis and anti-HIV evaluation. (2000) (10)
FUNCTIONAL T4 HELPER CELLS IN PATIENT WITH HTLV RELATED SÉZARY SYNDROME (1983) (10)
HIV-1 protease inhibitors containing statine: inhibitory potency and antiviral activity. (1992) (10)
Cellular and molecular mechanisms of antiretroviral effects of HPA23. (1988) (10)
New 3′-Azido-3′-deoxythymidin-5′-yl O-(ω-Hydroxyalkyl) Carbonate Prodrugs: Synthesis and Anti-HIV Evaluation. (2001) (9)
Thiophenoxy peptides: A new class of HIV replication inhibitors (1996) (9)
Characterization of the purified RNA dependent DNA polymerase isolated from Drosophila. (1987) (9)
Synthesis of tetrazole oxathiolane nucleoside analogues and their evaluation as HIV-1 antiviral agents (1992) (9)
Cultured trophoblastic choriocarcinoma cells differentially express HIV-1 and cloned provirus. (1991) (8)
Synthesis and comparative anti-HIV activities of new acetylated 2′,3′-dideoxy-3′-thiacytidine analogues (1994) (8)
Lectin Effects on HIV‐1 Infectivity (1994) (8)
Fusogenic determinants of highly cytopathic subtype D Zairian isolate HIV-1 NDK. (1995) (8)
Synthesis and antiviral activity of new carbonylphosphonate 2',3'-dideoxy-3'-thiacytidine conjugates. (1994) (8)
Acute and regressive encephalopathy coincident with transient isolation of human immunodeficiency virus from cerebrospinal fluid of a seropositive man. (1988) (8)
Synthesis and Biological Evaluation of a New N4-(N-Formyl Peptide)- 2′,3′-Dideoxy-3′-Thiacytidine as Anti-Hiv Prodrug (1993) (8)
LYMPHADENOPATHY ASSOCIATED VIRUS IN AIDS, LYMPHADENOPATHY ASSOCIATED SYNDROME, AND CLASSIC KAPOSI PATIENTS IN GREECE (1984) (8)
HIV Tat protein potentiates in vitro granulomonocytic progenitor cell growth (1995) (8)
Transient stimulation of granulopoiesis and drastic inhibition of erythropoiesis in HIV-2-infected long-term liquid bone marrow cultures. (1992) (8)
Synthese et etude de 5H-pyrido[4,3-b]-benzo[f]indoloquinones-6,11 apparentees aux ellipticines et aux anthracyclines (1985) (7)
Reverse transcriptase activity (RTA) in lymphocyte cultures of HIV-infected patients receiving short treatments of HPA 23. A biological evaluation. (1988) (7)
ANTIBODIES TO HTLV I AND III IN SERA FROM TWO JAPANESE PATIENTS, ONE WITH POSSIBLE PRE-AIDS (1984) (7)
Syntheses of new modified Phe-Pro peptides. Use of proline replacements in potential HIV inhibitors. (1998) (7)
[HIV virus detection in ejaculates collected at different times in seropositive patients]. (1997) (7)
Short and unexpectedly potent 3-pyrrolidinone type inhibitors of HIV-1 replication (1998) (7)
Modelisation, synthesis and antiviral evaluation of new 2,3-disubstituted thiazolidinone nucleoside analogues (1996) (6)
IMMUNE STATUS OF AIDS PATIENTS IN FRANCE: RELATIONSHIP WITH LYMPHADENOPATHY ASSOCIATED VIRUS TROPISM a (1984) (6)
SYNTHESIS AND ANTI-HIV SCREENING OF SOME HETEROCYCLIC COMPOUNDS (1997) (6)
Study of antivirus activity of mineral condensed polyanions. II. Effect on vesicular stomatitis virus. (1972) (6)
A recombinant human monoclonal anti-R7V antibody as a potential therapy for HIV infected patients in failure of HAART. (2008) (6)
Modelisation, Synthesis and Anti-HIV activities of N,N,N′,N″,N‴-pentakistetraazamacrocycles salts derivatives (1997) (6)
Biosynthesis of LAV gag gene products: presence of an intracellular gag-pol precursor polyprotein (1987) (6)
Use of monoclonal antibodies for the detection and quantitation of HIV1 core protein p25: comparative evaluation of in vitro HIV1 infection by immunofluorescence, antigen capture ELISA and reverse transcriptase assays. (1990) (6)
Tri-N-Boc-tetraazamacrocycle-nucleoside conjugates: synthesis and anti-HIV activities. (1998) (6)
Organ distribution of reverse transcriptase and cellular DNA polymerases in Friend virus-infected mice: analysis by phosphocellulose column chromatography. (1984) (5)
Discrepancies in AIDS virus data (1991) (5)
AIDS and Reproduction (1993) (5)
Prevalence of Antibodies to Lymphadenophahy‐AIDS Virus in French Haemophiliacs (1985) (5)
Infection of HIV-1 and HIV-2 through the luminal and serosal sides of polarized human intestinal epithelial cells. (1992) (5)
Characterization of a reverse transcriptase activity associated with retrovirus-like particles in a Drosophila cell line. (1989) (5)
LABORATORY AND SEROLOGICAL STUDIES ARGUE AGAINST POSSIBLE TRANSMISSION OF AIDS BY HEPATITIS B VACCINE (1985) (5)
Purification of Bacterial Endotoxins by Zonal Centrifugation (1972) (5)
Inhibition of DNA polymerase alpha activity by ammonium 21-tungsto-9-antimoniate (HPA23). (1984) (5)
Apoptosis of CD4+ T cells induced after contact with HIV1-infected or non-infected macrophages. (1997) (4)
Genetic control of infection of primary macrophages with T-cell-tropic strains of HIV-1. (1996) (4)
Neutralizing antibodies against highly cytopathic Zairian human immunodeficiency type-1 virus (HIV-1) NDK are present in sera outside Africa. (1995) (4)
A binding assay to identify HIV(LAV) target cells (1986) (4)
The etiologic agent of AIDS. (1986) (4)
Binding of human immunodeficiency virus type-1 (HIV-1) to partially purified membrane vesicles of lymphoblastoid cell line CEM. (1993) (4)
[Infection of insect cell lines by the HIV virus, an agent of AIDS, and a demonstration of insects of African origin infected by this virus]. (1986) (4)
A model allowing the design of modified nucleosides as HIV-RT inhibitors. (1996) (4)
Peptide-Nucleoside Conjugates: Synthesis and Anti-HIV Activities (1995) (4)
New anti-HIV derivatives: synthesis and antiviral evaluation. (2000) (4)
Synthesis and anti-HIV evaluation of new 2′,3′- dideoxy-3′-thiacytidine prodrugs (2000) (4)
[Preliminary investigation on the relation between clinical progress and anti-small monomolecular peptides antibody in individual infected with HIV]. (2002) (4)
Longitudinal assessment of persistent generalized lymphadenopathy (PGL) in homosexual men. (1985) (4)
Resistance of AIDS virus at room temperature [letter] (1985) (4)
The possible role of a new lymphotropic retrovirus (LAV) in the pathogeny of AIDS and AIDS-related diseases. (1985) (4)
New polyazamacrocycle-nucleoside conjugates: synthesis, anti-HIV evaluation and interaction with CXCR-4 coreceptor. (1999) (3)
[Inhibitors of the murine leukemia sarcoma group viruses. Silicotungstates]. (1971) (3)
Inactivation du «lymphadenopathy AIDS virus» (LAV) (1985) (3)
STRUCTURE-ACTIVITY RELATIONSHIPS IN A SERIES OF NEWLY SYNTHESIZED 1-AMINO-SUBSTITUTED ELLIPTICINE DERIVATIVES (1981) (3)
Productive infection of embryonal carcinoma cells with ecotropic mouse type C viruses and subsequent arrest of differentiation. (1982) (3)
Structural variability ofenv andgag gene products from a highly cytopathic strain of HIV-1 (2005) (3)
Synthesis and Anti-HIV Evaluation of New 5-Substituted-2′,3′-Dideoxy-3′-thiauridine Nucleosides (1996) (3)
Effects of thymus humoral factor gamma-2 (THF gamma 2) on lymphohaematopoietic progenitor cells: an in vitro study. (1993) (3)
Characterization of HIV1-PAR, a macrophage-tropic strain: cell tropism, virus/cell entry and nucleotide sequence of the envelope glycoprotein. (1993) (3)
Metabolism of 5' deoxy-5'[35S]-isobutyl-thio-adenosine (SIBA) in rats and mice. (1980) (3)
Immunohistochemical reactivity of anti-LAV p18 monoclonal antibody in lymph nodes from PGL and AIDS patients. (1985) (3)
Seropositivity to LAV/HTLV-III in 11 European countries. (1986) (3)
Induction of cellular DNA polymerases in a Burkitt lymphoma-derived cell line by treatment with 5-iododeoxyuridine. (1984) (2)
A new human retrovirus associated with acquired immunodeficiency syndrome (AIDS) or AIDS-related complex. (1985) (2)
RNA-dependent DNA polymerase activity is regulated by ecdysterone in a Drosophila cell line. (1988) (2)
Tri‐N‐Boc‐tetraazamacrocycle—Nucleoside Conjugates: Synthesis and Anti‐HIV Activities. (2010) (2)
New HIV plaque titration; application to the assay of neutralizing antibody. (1993) (2)
Selection of an HIV-1 variant following anti-CD4 treatment of infected cells (1991) (2)
A brief reflection on the development of human retrovirology: the past, the present and the future. (2001) (2)
Human Immunodeficiency Virus (HIV) (1990) (2)
[Retroviruses and acquired immunodeficiency syndrome (AIDS)]. (1984) (2)
[Antiviral action of condensed mineral polyanions. In vitro inhibition of rubella virus]. (1972) (2)
Molecular Characterization of a Highly Cytopathic Strain of the Human Immunodeficiency Virus Type 1 (1988) (2)
HIV antibodies in Mauritania. (1987) (2)
HIV Reverse Transcriptase (RT) and HIV Protease Inhibitors (1997) (2)
Western blot technique in the serological evaluation of three LAV/HTLV III-infected Italian families (1986) (2)
Synthesis and biological evaluation of polyaminated 2',3'-dideoxy-3'-thiacytidine prodrugs. (1999) (2)
Effects of STAS JLSV5 and silicotungstate on the replication of murine sarcoma virus (Moloney) and poliovirus. (1973) (2)
Analysis and Immunological Properties of Lymphadenopathy Associated Virus (LAV) Structural Proteins (1985) (2)
[Inhibitors of viruses of the leukemia and murine sarcoma group. Biological inhibitor CJMR]. (1971) (2)
Interrelations of lymphocyte subset values, human immunodeficiency virus antibodies, and HIV antigen levels of homosexual males in San Francisco. (1988) (2)
11H-PYRIDO(3′,2′:4,5)PYRROLO(2,3-G)ISOQUINOLINES (7-AZAELLIPTICINES) SUBSTITUTED AT POSITION 6 (1981) (2)
Characterization of monoclonal antibodies directed against distinct conserved epitopes of human immunodeficiency virus type 1 core proteins (1990) (2)
Vaccine against infectious agents having an intracellular phase, composition for the treatment and prevention of HIV infections, antibodies and diagnostic METHOD (1995) (1)
Stimulation of bystander T-cell proliferation by tumor necrosis factor produced by HIV-1-infected macrophages. (1998) (1)
Surface Marker Data and Functional Analysis of Hemophilia Patients with and without Antibodies to LAV1 (1986) (1)
Experimental conditions that increase the production of HIV-1 by monocyte-derived macrophages: use of collagen matrix. (1999) (1)
Replication of primate oncornavirus SSV-1 on MRC-5 human diploid cells. (1976) (1)
Assessment of LAV1 Antibodies in Hemophilia Patients with Distinct Types of Factor VIII Substitution: Striking Absence of LAV1 Antibodies After Exclusive Use of Heat-Treated Factor VIII Concentrates (1986) (1)
[Demonstration of an antiviral substance in the culture medium of cells of the NZB mouse]. (1973) (1)
REPLICATION OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 WITH PRIMARY CULTURED PLACENTAL CELLS IN VITRO (1991) (1)
A Novel Human Lymphotropic Retrovirus (LAV): New Data on Its Biology and Role in AIDS (1985) (1)
Characterization of monoclonal antibodies identifying type and strain-specific epitopes of human immunodeficiency virus type 1 (1991) (1)
In vitro study of Seraspenide on HIV‐induced inhibition of granulopoiesis (1997) (1)
Lymphadenopathy associated virus (L.A.V.): its association with AIDS or prodromes. (1985) (1)
Differential inhibition by an antitumoral drug 10-[gamma-diethylaminopropylamino]-6-methyl-5H-pyrido[3',4': 4,5]pyrrolo [2,3-G]isoquinoline (BD-40), a pyrido-pyrrolo-isoquinoline derivative, of in vitro DNA synthesis catalyzed by various DNA polymerases. (1990) (1)
Synthesis and Antiviral Activity of a Potential Prodrug: N4-Retinoyl-3′ -thia-2′,3′-dideoxycytidine. (1994) (1)
Studies on the mechanism of action of ammonium-5-tungsto-2-antimoniate (HPA 23). (1975) (1)
[Prevalence of anti-LAV antibodies in hemophiliacs, correlation with the immunological state]. (1985) (1)
[Cytotoxic and antitumor activity of a new series of heterocyclic compounds: dipyrido (4,3-b) (3,4-f) indoles]. (1977) (1)
Neutralizing antibodies in Brazilian sera against three strains of human immunodeficiency virus type 1 (HIV-1). (1997) (1)
[Zonal centrifuge purification of human rabies vaccine obtained on bovine foetal kidney cells (author's transl)]. (1977) (1)
Role of the human immunodeficiency virus in the physiopathology of AIDS. (1987) (1)
SYNTHESIS AND BIOLOGICAL ACTIVITY OF N-(N,N-DIALKYLAMINOALKYL)-1-AMINOMETHYL-5-METHYL-9-METHOXY(6H)PYRIDO(4,3-B)CARBAZOLES (ELLIPTICINES) (1985) (1)
Synthesis and anti-HIV Activity of α-Thiophenoxy-hydroxyethylamide Derivatives. (2000) (1)
HIV Materno-foetal transmission (1989) (0)
LYMPHOCYTE ADHESION AND TRANSMIGRATION THROUGH KAPOSI'S SARCOMA CELLS. STUDY IN STATIC AND DYNAMIC FLOW MODELS.: 44 (1997) (0)
Expression vector containing dna insert fragment hybridizable with genomic rna of llymphadenophaty-associated vitrus and its expression product (1996) (0)
Modelization, Synthesis and Antiviral Evaluation of New 2,3‐ Disubstituted Thiazolidinone Nucleoside Analogues. (1996) (0)
[Occurrence of false positives in tests with synthetic peptides for the analysis of antibodies against the human immunodeficiency virus type 2 (HIV-2) in Brazilian patients infected with the human immunodeficiency virus type 1 (HIV-1)]. (1996) (0)
Non-identity of r1, r2, r3, heterologous antigens with Kunin's, " common antigen". (1967) (0)
LYMPHADENOPATHY (PGL) IN HOMOSEXUAL MEN (1985) (0)
LAV antigens and peptides (1985) (0)
[The rough granular endotoxins: toxic properties]. (1966) (0)
Differential effect of methyl-isobutyl-amino-adenosine (MIBUNA) on murine leukaemia virus replication and on the cellular transformation as induced by murine sarcoma virus* (1982) (0)
[Studies on the extraction of somatic antigens (R and O) from bacterial walls of Salmonella. Preparation of granular endotoxins]. (1966) (0)
[Study of various antigens extracted from rough Salmonella typhi (strain R 2). I. Qualitative study]. (1965) (0)
Rna corresponding to lymphadenopathy-associated virus(lav) genome, obtainable from reverse transcription of cloned dna hybridizable with genomic rna of lav (1994) (0)
Antigen and virus, method of preparation of the antigen, using antigens in the preparation of immunogenic compositions or for the diagnosis of antibodies against the virus (1986) (0)
Studies on the Mechanism of Action of Ammonium-5-tungsto-2-antimoniate (HPA 23)1 (1976) (0)
New Polyazamacrocycle-Nucleoside Conjugates: Synthesis, Anti-HIV Evaluation and Interaction with CXCR-4 Coreceptor (1999) (0)
F antigenic by the human immunodeficiency virus and uses thereof. (1985) (0)
Antigen to virus for lymphadenosis and/or acquired immune deficiency syndrome (aids) (1996) (0)
[Increase of leukemogenic activity after precipitation by polyethylene glycol of Friend virus]. (1969) (0)
Syntheses of New Modified Phe—Pro Peptides. Use of Proline Replacements in Potential HIV Inhibitors. (1998) (0)
[Immunological relationship between neurotoxin and heavy purified endotoxins extracted from "Shigella dysenteriae" (Shiga), smooth and rough forms (author's transl)]. (1974) (0)
Lymphadenopathy-associated huellenantigene and their uses. (1985) (0)
Evidence of an inhibitor of Friend leukaemia. (1970) (0)
355 Vertical transmission of AIDS. (1991) (0)
IMMUNOGLOBULIN IgG3 MARKER PROTECTION AGAINST INFECTIOUS VIRAL DISEASES AND USES (2002) (0)
Immunological relationship between neurotoxin and heavy purified endo-toxins extracted from Shigella dysenteriae(Shiga), smooth and rough forms. (1974) (0)
Antigen, process for the preparation of the antigen, method of diagnosing and immunogenic compositions (1986) (0)
Human immunodeficiency virus can infect the apical and basolateral surfaces of human colonic epithelial cells. (1991) (0)
Evidence that membrane proteins of rhabdomyosarcoma cell line RD bind human immunodeficiency virus type 1 (HIV-1). (1993) (0)
IgG3 immunogloblin as protection against virus marker infectious diseases and its uses (2003) (0)
Heteropolyanion compounds, their production and drug-containing (1977) (0)
Cloned DNA sequences hybridizable with genome-rns from "lymphadenopathy-associated virus (LAV)." (1985) (0)
Study of antigens produced by Salmonella typhi (rough strain, R2). II. Separation and properties. (1967) (0)
Vaccine against pathogens, composition for the treatment and prevention of HIV infections (1996) (0)
Cloned dna containing dna insert fragment hybidizable with genomic rna of lymphadenopathyl-associnated virus(lav) (1996) (0)
[Multiplicity of determinants present in the molecule of the heavy rough Salmonella antigen]. (1967) (0)
Purification of PO, Antigenic Subfraction of the Endotoxin Extracted from S. typhi O 901 (1975) (0)
[Study of the immuno-stimulating effect of various species of anaerobic Corynebacteriae and of their fractions]. (1972) (0)
Use of peptide inhibitors of proteases acids for the preparation of medicaments useful for the treatment of viral diseases (1989) (0)
Evidence for the possible role of a new family of retroviruses in aids (1985) (0)
Search for antiviral drugs against rabies virus infection (1985) (0)
Short and Unexpectedly Potent 3-Pyrrolidinone Type Inhibitors of HIV-1 Replication. (1999) (0)
LAV Virus, the Etiological Agent of AIDS (1987) (0)
Synthesis and anti-HIV activities of symmetrical N1,N3-dibenzyl-2-hydroxy-propane derivatives. (1998) (0)
Lymphadenopathy Associated Virus (LAV) as the Primary Etiologic Agent of AIDS and Therapeutic Perspectives (1986) (0)
Cloned dna containing dna insert fragment hybridizable with genomic rna of lav virus (1996) (0)
[A reply to the doubts concerning the agent of AIDS]. (1988) (0)
[Non-identity of the heterologous antigens r 1, r 2, r 3 and the common Kunin antigen]. (1967) (0)
[A new method of purification of endotoxins: precipitation by polyethylene glycol]. (1967) (0)
Human immunodeficiency virus inhibition by lysed leukocyte ultrafiltrate. (1990) (0)
Genetic comparison of LAV-related isolates. (1987) (0)
Synthesis and Comparative anti-HIV Activities of New Acetylated 2′,3′- Dideoxy-3′-thiacytidine Analogues. (1994) (0)
Synthesis and anti‐HIV Evaluation of New 2′,3′‐Dideoxy‐3′‐thiacytidine Prodrugs. (2002) (0)
Compositions Pharmaceutical drug for the treatment of the syndrome of the acquired immunodeficiency syndrome (AIDS) and related (1985) (0)
Role of white Cells in Reagents for AIDS (1987) (0)
[Properties of very active murine leukemogenic virus inhibitor]. (1970) (0)
Properties of new inhibitors of murine leukaemia and sarcoma viruses. (1971) (0)
[Research of status of provirus HIV DNA in non-progressor and progressor of HIV-1 infected persons]. (2000) (0)
Thiophenoxy Peptides: A New Class of HIV Replication Inhibitors. (1996) (0)
Using dipyrido (4,3-b) (3,4-f) indoles for the preparation of medicaments useful for the treatment of AIDS (1989) (0)
[On a new form of endotoxin: "granular" endotoxins]. (1966) (0)
1-Amino-di:methyl-di:pyrido-indole derivs. - useful for treating leukaemia and tumours (1980) (0)
Immunoglobulin IgG3 as a marker for protection against infectious viral diseases, and their uses. (2003) (0)
Structure-antiviral activity relationship in pseudo-peptides containing statine or statine-like derivatives (1993) (0)
Synthesis and Antiviral Activity of N‐4′‐Dihydropyridinyl and Dihydroquinolinylcarbonyl‐2‐hydroxymethyl‐5‐(cytosin‐1′‐yl)‐1,3‐ oxathiolane Derivatives (V) Against Human Immunodeficiency Virus and Duck Hepatitis B Virus. (1996) (0)
Tungsten and antimony-containing heteropolyanionverbindung and their use in medicaments (1974) (0)
2-L-Rhamnopyranosyl[1,2,4]triazolo[1,5-α]pyridine. 4′- and 3′- Oxidation Products. Synthesis and Structure-Activity Relationships. Synthesis of C-Nucleosides. Part 19. (1982) (0)
Low polypeptide encoded by DNA sequence (1993) (0)
HIV: the etiologic agent of AIDS and associated diseases. (1988) (0)
[Study of various antigens produced by Salmonella typhi rough (R2 strain). II. Fractionation and properties]. (1967) (0)
Synthesis and anti‐HIV Evaluation of New 5‐Substituted‐2′,3′‐dideoxy‐3′ ‐thiauridine Nucleosides. (1996) (0)
ANTITUMOR AMINO-SUBSTITUTED PYRIDO(3′,4′:4,5)PYRROLO(2,3-G)ISOQUINOLINES AND PYRIDO(4,3-B)CARBAZOLE DERIVATIVES: SYNTHESIS AND EVALUATION OF COMPOUNDS RESULTING FROM NEW SIDE CHAIN AND HETEROCYCLE MODIFICATIONS (1983) (0)
SYNTHESIS OF C-NUCLEOSIDES. XVIII. D-ARABINOFURANOSYL S-TRIAZOLOPYRIDINES AND D PYRAZINES (1980) (0)
Immunonanoparticules coated with monoclonal anti-beta2 microglobulin antibodies and their use for the prophylaxis and / or treatment of pathologies due to infection with the HIV virus (1994) (0)
Huellenantigene by the human immunodeficiency virus and uses thereof. (1985) (0)
SYNTHESIS OF 1,10-DISUBSTITUTED 5H-PYRIDO(3′,4′:4,5)PYRROLO(2,3-G)ISOQUINOLINES (9-AZAELLIPTICINES) (1985) (0)
Antigens encoded by the gag open reading frame (gag open reading frame) of the LAV viruses, their use in the manufacture (1993) (0)
SYNTHESIS AND STUDY OF 5H-PYRIDO(4,3-B)BENZO(F)INDOLO-6,11-QUINONES RELATED TO ELLIPTICINES AND ANTHRACYCLINES (1985) (0)
Design, synthesis and structure relationships of new N,N',N",N"'-tetrakis (omega-amino alkyl) tetraazamacrocycles. (1998) (0)
Special lectures VIII. AIDS. (1992) (0)
Envelope antigens from the human immunodeficiency virus and uses thereof. (1985) (0)
TheHumanImmunodeficiency Virus(HIV) gag GeneProduct p18 IsResponsible forEnhancedFusogenicity andHostRange TropismoftheHighlyCytopathic HIV-1-NDKStrain (1992) (0)
[Reticulostimulating activity of the walls of anaerobic Corynebacteria]. (1972) (0)
Purified and isolated retrovirus of hiv (1993) (0)
RETROVIRUS INFECTION OF ENTEROCYTES: DO THEY OR DON'T THEY? (1992) (0)
Production of envelop antigen of lymphadenopathy and acquired immune deficiency syndrome virus and use of the antigen for preparing immunogen composition or detecting antibody against the virus (1994) (0)

This paper list is powered by the following services:

Jean‐claude Chermann's Academic­Influence.com Rankings

Jean‐claude Chermann's Degrees

Why Is Jean‐claude Chermann Influential?

Jean‐claude Chermann's Published Works

Published Works

Jean‐claude Chermann's AcademicInfluence.com Rankings